Displaying items by tag:

With his idea for a coil that travels through the vasculature much like a sailboat riding the breeze, a UAB neuroradiologist has earned a commercialization grant from the U.S. Economic Development Administration.

Benjamin Larimer, Ph.D., has received a five-year, $1.5-million New Innovator Award grant to develop a PET imaging test that identifies patients most likely to benefit from immunotherapy.

Department creates environment for entrepreneurial activity that fuels advances in artificial intelligence, cancer prediction and patient safety.

In this project supported through UAB’s urgent COVID-19 research fund, Assistant Professor Benjamin Larimer, Ph.D., adapts his lab’s work on phage display — normally used to identify new cancer treatments — to overcome limitations of antibody and vaccine testing.

New UAB research is combining mathematical modeling and advanced imaging to find the right mix of therapy for patients with a common subtype of breast cancer.

An experimental PET scan developed by new radiology faculty member Ben Larimer, Ph.D., captures T cells in the act of destroying tumors. A first-in-humans clinical trial is set to start at UAB this fall.

A new discipline sits at the intersection of neuroscience and engineering, where lessons learned from circuits, networks and chips are combined with the latest findings on brain circuitry.

Pay-to-publish journals are often outright scams and undermine the foundation of legitimate research, says Arline Savage, Ph.D. Here’s how faculty and their departments can defend themselves.

More than 300 employees with 20-plus years of service to UAB will be honored March 1.

Vattoth is a scientist in UAB’s Comprehensive Neuroscience Center.
Chapman has been on staff since 2008 and has been named chief of neuroradiology

Researchers are working on a drug-delivery method specially designed to target cancer tumors.